Endoscopic surgery versus IMRT for resectable locally recurrent NPC

A multicenter phase 3 study in China compared salvage endoscopic surgery versus IMRT for locally recurrent nasopharyngeal carcinoma in patients who had previously received radiotherapy. The 3-year overall survival was 85.8% in the surgery group versus 68.0% in the IMRT group (HR 0.47; p=0.0015).